MedTrace Logo

Obese Patients With Type 2 Diabetes

NCT00029848 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1045

Last updated 2009-04-20

No results posted yet for this study

Summary

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Conditions

  • Obesity
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Obesity in Diabetes

Interventions

DRUG

Rimonabant (SR141716)

Sponsors & Collaborators

Principal Investigators

  • ICD CSD · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2004-05-31
Completion
2004-05-31

Countries

  • United States
  • Argentina
  • Belgium
  • Canada
  • Czechia
  • Finland
  • France
  • Germany
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00029848 on ClinicalTrials.gov